Is phototherapy (UVB) safe
Surprisingly, glucagon, which is used to treat severe hypoglycemia by targeting the glucagon receptor and is a weak agonist for GLP-1R 26 , was also found to activate a subset of the pathways elicited by GLP-1 (7-36) stimulation 5 , underlining the importance of investigating polypharmacology
It is initiated by the activation of inflammasomes, which activate inflammatory caspases (such as caspase-1, -4, -5, and -11), leading to cleavage of Gasdermin D (GSDMD)
Dulaglutide (Trulicity) Strengths: Once-weekly dosing Easy-to-use auto-injector device Proven cardiovascular benefit Good tolerability profile Considerations: Less weight loss than semaglutide Moderate (not maximum) glucose efficacy Best for: Patients prioritizing convenience and tolerability over maximum efficacy
Further research and clinical studies are needed to evaluate the performance of this GSH-based modification in fat transplantation